Relay Therapeutics Inc (RLAY)

R&D Expense Growth

-18.08%

Fiscal year · Period ending:

RLAY logo

RLAY R&D Expense Growth

Latest reported-18.08%
RLAY FY R&D Growth (YoY) (0.00% → -18.08%)
High-resolution chart · PNG

RLAY r&d expense growth history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Relay Therapeutics Inc R&D Expense Growth — Annual fiscal periods
Period endingR&D Expense Growth
-18.0846%
-3.3116%
33.9603%
-16.6734%
196.0586%
42.0391%
71.336%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.